Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc. financial statements

Collegium Pharmaceutical, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 780.57M10-K
Net incomeUSD 62.87M10-K
Cash and equivalentsUSD 231.25M10-Q
Total debtUSD 940.56MEODHD

Collegium Pharmaceutical, Inc. financials on 6ix · Collegium Pharmaceutical, Inc. on 6ix